CoreAge Rx vs Rivo Health
An in-depth comparison of two leading GLP-1 Providers
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
CoreAge Rx
Best for: semaglutide at $99/month, 48% under the register median
Visit CoreAge Rx →
Two GLP-1 Providers chasing the same patients, trading off price, geography and what lands in the box differently. On our scoring, CoreAge Rx opens cheaper — $99/mo against $149, and CoreAge Rx finishes ahead, 9.1 to 8.3. What follows: the prices, what each plan actually covers, the six-dimension score, where each one is weak, and who should pick which.
Pricing
CoreAge Rx
Re-verified 2026-08-05: homepage + Preventive Longevity section both show "Semaglutide — Starting at $99/mo", "Same price at every dose"; supersedes stale tiered pricing captured 2026-06-05.
Re-verified 2026-08-05: homepage GLP-1 hero + Preventive Longevity section both show "Tirzepatide — Starting at $149/mo", "Same price at every dose"; supersedes stale tiered pricing captured 2026-06-05.
Rivo Health
Starting $149/mo (Spring sale, up to ~50% off retail); 3-mo and 6-mo plans save more
Oral semaglutide option, same starting price as the injection
Starting $199/mo (Spring sale); multi-month plans save more
Oral tirzepatide option, same starting price as the injection
What’s included
CoreAge Rx
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Rivo Health
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Score breakdown
Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.
CoreAge Rx
9.1/10
Rivo Health
8.3/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
Features & Coverage
| Feature | CoreAge Rx | Rivo Health |
|---|---|---|
| Starting Price | ✓$99/mo | $149/mo |
| Features | 6 features | ✓8 features |
| States Available | 50 | 50 |
| Compounded | ✓ Yes | — |
| Brand Name | — | — |
| FSA/HSA Accepted | — | ✓ Yes |
| FDA Warnings | None | None |
About CoreAge Rx
Shipping is free, 2-day, and reaches all 50 states. CoreAge Rx sells LegitScript-verified compounded semaglutide plus tirzepatide, with licensed physicians behind it and 24/7 support. Its own claim: nobody in the compounded GLP-1 space prices more competitively.
Read our full CoreAge Rx review →About Rivo Health
Semaglutide begins around $149/mo, tirzepatide around $199/mo, both compounded GLP-1, available as injections or orally, with 3- and 6-month terms cutting deeper. By its own account Rivo has 115,000+ members and a Trustpilot score of 4.7. What comes attached to the drug is unusual: dietitians, live workouts, support groups, mental-health coaching, and an insurance concierge whose job is squeezing more out of your coverage. FSA/HSA money is eligible. ED, longevity through NAD+ and sermorelin, sleep, hair and skin fill the rest of the catalog. Its partner compounding pharmacies go unnamed.
Read our full Rivo Health review →Pros & Cons
CoreAge Rx
What we like
- Semaglutide at $99 a month, 48% below the $189 median for the same drug and form across this register
- Tirzepatide at $149 a month, 44% below the $267 median for the same drug and form across this register
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- The monthly figure covers medication, consult, shipping
- Coverage is published for all 50 states
- No FDA warning letter matched this operator when we searched our enforcement register
Watch-outs
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Rivo Health
What we like
- Semaglutide at $149 a month, within the normal band around this register's $189 median for the same drug and form
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- The monthly figure covers medication, consult, coaching
- Coverage is published for all 50 states
- No FDA warning letter matched this operator when we searched our enforcement register
- Both oral and injectable options are on record, so the format is a choice rather than a condition
Watch-outs
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
CoreAge Rx takes it, 9.1 against 8.3, and it is especially strong on semaglutide at $99/month, 48% under the register median. Rivo Health is no weak second and may fit you better on an oral route if you will not self-inject.
Choose CoreAge Rx if…
You want semaglutide at $99/month, 48% under the register median and an opening price near $99 a month.
Choose Rivo Health if…
You want an oral route if you will not self-inject and an opening price near $149 a month.
Ready to start? Vetted GLP-1 providers
Vetted telehealth providers that prescribe GLP-1 online.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Found
Tirzepatide at $169/month, 37% under the register median
From $99/mo
Get started →Telos Rx
Starting below a standard dose, with microdose tiers
From $49/mo
Get started →MyDrHank
An oral route if you will not self-inject
From $25/mo
Get started →CoreAge Rx vs Rivo Health: FAQ
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring CoreAge Rx and Rivo Health head-to-heads in the same category.
- CoreAge Rx vs Trimi Health
- CoreAge Rx vs Embody
- CoreAge Rx vs He & She MD
- Rivo Health vs Lean Meds
- Rivo Health vs NextMeds
- Rivo Health vs bmiMD
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.